Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AstraZeneca

    OTC: AZNCF · Real-Time Price · USD
    148.04
    -2.06 (-1.38%)
    At close: Jun 13, 2025, 3:42 PM

    AstraZeneca Statistics

    Share Statistics

    AstraZeneca has 1.55B shares outstanding. The number of shares has increased by 0.02% in one year.

    Shares Outstanding

    n/a
    		 1.55B

    Shares Change (YoY)

    n/a
    		 0.02%

    Shares Change (QoQ)

    n/a
    		 0.02%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 1.47B

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 190.55K, so 0.01% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 190.55K

    Short % of Shares Out

    n/a
    		 0.01%

    Short % of Float

    n/a
    		 0.01%

    Short Ratio (days to cover)

    n/a
    		 50.58

    Valuation Ratios

    The PE ratio is 28.64 and the forward PE ratio is 14.73. AstraZeneca's PEG ratio is 1.57.

    PE Ratio

    n/a
    		 28.64

    Forward PE

    n/a
    		 14.73

    PS Ratio

    n/a
    		 3.73

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 4.94

    P/FCF Ratio

    n/a
    		 27.7

    PEG Ratio

    n/a
    		 1.57
    Financial Ratio History

    Enterprise Valuation

    AstraZeneca has an Enterprise Value (EV) of 226.13B.

    EV / Sales

    n/a
    		 4.18

    EV / EBITDA

    n/a
    		 14.65

    EV / EBIT

    n/a
    		 19.06

    EV / FCF

    n/a
    		 31.08

    Financial Position

    The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.74.

    Current Ratio

    n/a
    		 0.93

    Quick Ratio

    n/a
    		 0.74

    Debt / Equity

    n/a
    		 0.74

    Debt / EBITDA

    n/a
    		 1.95

    Debt / FCF

    n/a
    		 4.14

    Interest Coverage

    n/a
    		 5.95

    Financial Efficiency

    Return on Equity is 17.25% and Return on Invested Capital is 10.3%.

    Return on Equity

    n/a
    		 17.25%

    Return on Assets

    n/a
    		 6.76%

    Return on Invested Capital

    n/a
    		 10.3%

    Revenue Per Employee

    n/a
    		 $573,414.63

    Profits Per Employee

    n/a
    		 $74,602.33

    Employee Count

    n/a
    		 94,300

    Asset Turnover

    n/a
    		 0.52

    Inventory Turnover

    n/a
    		 1.93

    Taxes

    Income Tax

    n/a
    		 1.65B

    Effective Tax Rate

    n/a
    		 18.99%

    Stock Price Statistics

    The stock price has increased by -7.72% in the last 52 weeks. The beta is 0.17, so AstraZeneca's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.17

    52-Week Price Change

    n/a
    		 -7.72%

    50-Day Moving Average

    n/a
    		 139.35

    200-Day Moving Average

    n/a
    		 143.35

    Relative Strength Index (RSI)

    n/a
    		 59.71

    Average Volume (20 Days)

    n/a
    		 2,126

    Income Statement

    In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 4.54.

    Revenue

    n/a
    		 54.07B

    Gross Profit

    n/a
    		 43.87B

    Operating Income

    n/a
    		 10B

    Net Income

    n/a
    		 7.04B

    EBITDA

    n/a
    		 15.44B

    EBIT

    n/a
    		 10.37B

    Earnings Per Share (EPS)

    n/a
    		 4.54
    Full Income Statement

    Balance Sheet

    The company has 5.49B in cash and 30.11B in debt, giving a net cash position of -24.63B.

    Cash & Cash Equivalents

    n/a
    		 5.49B

    Total Debt

    n/a
    		 30.11B

    Net Cash

    n/a
    		 -24.63B

    Retained Earnings

    n/a
    		 3.16B

    Total Assets

    n/a
    		 106.31B

    Working Capital

    n/a
    		 -2.99B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 11.86B and capital expenditures -4.59B, giving a free cash flow of 7.28B.

    Operating Cash Flow

    n/a
    		 11.86B

    Capital Expenditures

    n/a
    		 -4.59B

    Free Cash Flow

    n/a
    		 7.28B

    FCF Per Share

    n/a
    		 4.69
    Full Cash Flow Statement

    Margins

    Gross margin is 81.12%, with operating and profit margins of 18.5% and 13.01%.

    Gross Margin

    n/a
    		 81.12%

    Operating Margin

    n/a
    		 18.5%

    Pretax Margin

    n/a
    		 16.07%

    Profit Margin

    n/a
    		 13.01%

    EBITDA Margin

    n/a
    		 28.55%

    EBIT Margin

    n/a
    		 18.5%

    FCF Margin

    n/a
    		 13.45%

    Dividends & Yields

    AZNCF pays an annual dividend of $5.08, which amounts to a dividend yield of 2.14%.

    Dividend Per Share

    n/a
    		 $5.08

    Dividend Yield

    n/a
    		 2.14%

    Dividend Growth (YoY)

    n/a
    		 7.97%

    Payout Ratio

    n/a
    		 102.29%

    Earnings Yield

    n/a
    		 3.49%

    FCF Yield

    n/a
    		 3.61%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for AZNCF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $53.53

    Lynch Upside

    n/a
    		 -63.84%

    Graham Number

    n/a
    		 51.84

    Graham Upside

    n/a
    		 -64.98%

    Scores

    Altman Z-Score

    n/a
    		 2.92

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist